ImportantUpdates
Venus Remedies (VENUSREM) renewed crucial R&D recognition, validating its commitment to antimicrobial resistance research.
Venus Remedies LimitedVENUSREM · Filed with the exchange
This supports innovative drug development, including USFDA-designated VRP-034, signaling a strong future pipeline.
No comments yet. Be the first.